Cargando…
Association Between Medicare's National Coverage Determination and Utilization of Next-Generation Sequencing
PURPOSE: In 2018, Medicare issued a national coverage determination (NCD) providing reimbursement for next-generation sequencing (NGS) tests for beneficiaries with advanced or metastatic cancer and no previous NGS testing. We examined the association between NCD implementation and NGS utilization tr...
Autores principales: | Sheinson, Daniel M., Wong, William B., Flores, Carlos, Ogale, Sarika, Gross, Cary P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600504/ https://www.ncbi.nlm.nih.gov/pubmed/34043456 http://dx.doi.org/10.1200/OP.20.01023 |
Ejemplares similares
-
Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage Determination
por: Sheinson, Daniel M., et al.
Publicado: (2021) -
The Cost of Cancer-Related Physician Services to Medicare
por: Maroongroge, Sean, et al.
Publicado: (2015) -
Utilization of Medicare services by beneficiaries having partial Medicare coverage
por: McCall, Nelda
Publicado: (1983) -
BAMscale: quantification of next-generation sequencing peaks and generation of scaled coverage tracks
por: Pongor, Lorinc S., et al.
Publicado: (2020) -
Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC
por: Lee, Jay M., et al.
Publicado: (2023)